Ravaioli A, Crocetti E, Bucchi L, Guzzinati S, Casella C, Falcini F, Ferretti S, Giuliani O, Mancini S, Puppo A, Toffolutti F, Zamagni F, Zorzi M, Dal Maso L, Serraino D; Gruppo di lavoro Registri tumori italiani.

Epidemiol Prev. 2022 Sep-Dec;46(5-6):356-366. doi: 10.19191/EP22.5-6.A489.095.


Objectives: to update the Italian estimates of survival for patients with a paediatric cancer, tobacco smoke-associated cancers, and cancers targeted by screening; to assess geographical differences.

Design: population-based descriptive study.

Setting and participants: incident cancer cases diagnosed in 2010-2014, with follow-up to 2018, from 17 Italian cancer registries (covering 31% of the national population; 43% of the population residing in the North-Centre of the country and 8% of the population living in the South and Islands).

Main outcome measures: age-standardized 5-year net survival (NS) by cancer site or type, sex, age, and geographical area.

Results: NS of patients aged ≥15 years with breast, prostate, colorectal, and lung cancers was higher in the North-Centre than in the South and Islands. The overall survival of people diagnosed with cancer in childhood (0-14 years) was 84.3%, with similar values among the geographical macro-areas and between males and females. Women with breast cancer within the current target age of the screening programmes and those in the younger age groups (45-49 years) show similar survival values; the same is true for women with colorectal cancer. In both cases, survival decreased in the age groups after the age of cessation of screening programmes. Survival of patients with tobacco smoke-associated cancers varies according to cancer site (from 11.1% for patients with pancreatic cancer to 79.7% for those with bladder cancer). For most cancer sites, women have higher survival than men.

Conclusions: for adults, a geographical survival gap persists. The results may contribute to the debate on extending the target age for screening programmes and to support initiatives to encourage tobacco smoking cessation even after cancer diagnosis. For patients who receive a cancer diagnosis in childhood, survival similar to highest values internationally.

Pubmed https://pubmed.ncbi.nlm.nih.gov/36458516/